[A methotrexate-associated lympholiferative disorder patient with gastrointestinal perforation].

[A methotrexate-associated lympholiferative disorder patient with gastrointestinal perforation].

Nihon Ronen Igakkai Zasshi. 2017;54(4):567-572

Authors: Aota Y, Nonaka T, Kimura S, Honda T, Okuda Y, Watanabe T, Fujiwara K, Yokoyama T, Wakabayashi Y, Sakurai M, Gotoh A

Abstract
A 70-year-old woman was diagnosed with chronic rheumatoid arthritis and treated with methotrexate and prednisolone. She visited our hospital to determine the cause of her continuous fatigue and fever for the past three weeks. She consumed no food orally and was provided antibiotics because free air was found on computed tomography (CT). Intraperitoneal small lymphadenopathy and swelling of both adrenal glands was also found on CT, and MTX-associated lymphoproliferative disorder (MTX-LPD) was suspected. Am adrenal gland biopsy showed diffuse large B-cell lymphoma (DLBCL) associated with MTX-LPD. The causes of gastrointestinal perforation with collagen diseases have been reported to be functional gastrointestinal disorders with collagen diseases like amyloidosis, gastrointestinal infections in immunocompromised patients, and side effects of medication, such as steroids or NSAIDs and MTX. MTX-LPD is an uncommon side effect of methotrexate. To ensure its appropriate diagnosis and treatment, it is important to improve the degree of recognition of MTX-LPD, and a prompt response is needed.

PMID: 29213000 [PubMed - in process]

http://ift.tt/2BfLlvC